COVID-19: Bajaj Healthcare receives DRDO licence for manufacture and sale of 2-DG
Bajaj Healthcare said in a regulatory filing it “…has received a licence from Defence Research and Development Organisation (DRDO) to Manufacture and Market of ‘2-Deoxy-D-Glucose’ as approved medication for the... Read More